What is the maximum approved dose of Jardiance (empagliflozin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Approved Dose of Jardiance

The maximum approved dose of Jardiance (empagliflozin) is 25 mg once daily. 1

Dosing Information

According to the FDA drug label, Jardiance is available in two tablet strengths:

  • 10 mg tablets
  • 25 mg tablets

Both doses are administered once daily and may be taken with or without food 1.

Clinical Context

The 25 mg dose represents the ceiling for therapeutic benefit in clinical practice. In clinical trials, doses up to 100 mg were studied for safety evaluation, but the approved maximum remains 25 mg for all indications 2. The dose-response relationship shows:

  • 10 mg dose: Produces urinary glucose excretion of approximately 64 grams per day
  • 25 mg dose: Produces urinary glucose excretion of approximately 78 grams per day 1

Both the 10 mg and 25 mg doses demonstrated similar efficacy for glycemic control (approximately 0.8% HbA1c reduction), with the 25 mg dose showing slightly greater effects on weight loss and blood pressure reduction 1, 3.

Special Populations

Heart Failure Patients: While 10 mg is the approved dose for heart failure indications, the 25 mg dose remains the maximum approved dose across all indications. Studies confirm that 10 mg exposure in heart failure patients is still below the 25 mg exposure in type 2 diabetes patients 4.

Renal Impairment: The maximum dose remains 25 mg, though glucose-lowering efficacy diminishes at eGFR <45 mL/min/1.73 m². The drug should be continued for cardiovascular and kidney benefits until dialysis or transplantation 5.

Important Caveat

Do not exceed 25 mg daily—higher doses (such as the 100 mg studied in research) are not approved and provide no additional clinical benefit while potentially increasing adverse effects 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.